| 1 |
Merchant N, Alam A, Bhaskar L. The correlation between hepatocellular carcinoma susceptibility and XRCC1 polymorphisms Arg194Trp, Arg280His, and Arg399Gln – A meta-analysis. Human Gene 2023. [DOI: 10.1016/j.humgen.2023.201165] [Reference Citation Analysis]
|
| 2 |
Zhou Q, Fu Y, Wen L, Deng Y, Chen J, Liu K. XPD Polymorphisms and Risk of Hepatocellular Carcinoma and Gastric Cancer: A Meta-Analysis. Technol Cancer Res Treat 2021;20:1533033821990046. [PMID: 33517857 DOI: 10.1177/1533033821990046] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 3 |
Xiong Y, Zhang Q, Ye J, Pan S, Ge L. Associations between three XRCC1 polymorphisms and hepatocellular carcinoma risk: A meta-analysis of case-control studies. PLoS One 2018;13:e0206853. [PMID: 30408066 DOI: 10.1371/journal.pone.0206853] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 4 |
Sahan AZ, Hazra TK, Das S. The Pivotal Role of DNA Repair in Infection Mediated-Inflammation and Cancer. Front Microbiol 2018;9:663. [PMID: 29696001 DOI: 10.3389/fmicb.2018.00663] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 5.2] [Reference Citation Analysis]
|
| 5 |
Wang B, Xu Q, Yang HW, Sun LP, Yuan Y. The association of six polymorphisms of five genes involved in three steps of nucleotide excision repair pathways with hepatocellular cancer risk. Oncotarget. 2016;7:20357-20367. [PMID: 26967386 DOI: 10.18632/oncotarget.7952] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 4.4] [Reference Citation Analysis]
|
| 6 |
Shi YH, Wang B, Xu BP, Jiang DN, Zhao DM, Ji MR, Zhou L, Li X, Lu CZ. The association of six non-synonymous variants in three DNA repair genes with hepatocellular carcinoma risk: a meta-analysis. J Cell Mol Med 2016;20:2056-63. [PMID: 27306318 DOI: 10.1111/jcmm.12896] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 7 |
Mathew S, Abdel-Hafiz H, Raza A, Fatima K, Qadri I. Host nucleotide polymorphism in hepatitis B virus-associated hepatocellular carcinoma. World J Hepatol 2016;8:485-98. [PMID: 27057306 DOI: 10.4254/wjh.v8.i10.485] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 8 |
Alavian SM, Haghbin H. Relative Importance of Hepatitis B and C Viruses in Hepatocellular Carcinoma in EMRO Countries and the Middle East: A Systematic Review. Hepat Mon 2016;16:e35106. [PMID: 27226803 DOI: 10.5812/hepatmon.35106] [Cited by in Crossref: 39] [Cited by in F6Publishing: 47] [Article Influence: 5.6] [Reference Citation Analysis]
|
| 9 |
Vedham V, Verma M, Mahabir S. Early-life exposures to infectious agents and later cancer development. Cancer Med 2015;4:1908-22. [PMID: 26377256 DOI: 10.1002/cam4.538] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 4.4] [Reference Citation Analysis]
|
| 10 |
Yang QI, Wei YF, Zhang Y, Huang GM. XPD Lys751Gln and Asp312Asn polymorphisms and hepatocellular carcinoma susceptibility: A meta-analysis of 11 case-control studies in an Asian population. Exp Ther Med 2015;9:2406-14. [PMID: 26136996 DOI: 10.3892/etm.2015.2421] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 11 |
Peng Q, Li S, Lao X, Chen Z, Li R, Qin X. Association between XPD Lys751Gln and Asp312Asn polymorphisms and hepatocellular carcinoma risk: a systematic review and meta-analysis. Medicine (Baltimore) 2014;93:e330. [PMID: 25546681 DOI: 10.1097/MD.0000000000000330] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 12 |
Su C, Lin Y, Niu J, Cai L. Association between polymorphisms in tumor suppressor genes and oncogenes and risk of hepatocellular carcinoma: a case-control study in an HCC epidemic area within the Han Chinese population. Med Oncol. 2014;31:356. [PMID: 25412941 DOI: 10.1007/s12032-014-0356-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 13 |
Luo HC, Zhang HB, Xin XJ, Huang WX. Haplotype-based case-control study of DNA repair gene XRCC3 and hepatocellular carcinoma risk in a Chinese population. Tumour Biol 2014;35:3415-9. [PMID: 24307625 DOI: 10.1007/s13277-013-1451-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 14 |
Wu D, Jiang H, Yu H, Xu D, Liang J, Jin J. Significant association between XRCC3 C241T polymorphism and increased risk of hepatocellular carcinoma: a meta-analysis. Tumour Biol 2013;34:3865-9. [PMID: 23873110 DOI: 10.1007/s13277-013-0973-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 15 |
Wu D, Jiang H, Gu Q, Zhang D, Li Z. Association between XRCC1 Arg399Gln polymorphism and hepatitis virus-related hepatocellular carcinoma risk in Asian population. Tumour Biol 2013;34:3265-9. [PMID: 23780894 DOI: 10.1007/s13277-013-0899-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 16 |
Zhang RC, Mou SH. Polymorphisms of excision repair gene XPD Lys751Gln and hOGG1 Ser326Cys might not be associated with hepatocellular carcinoma risk: a meta-analysis. Tumour Biol 2013;34:901-7. [PMID: 23271362 DOI: 10.1007/s13277-012-0625-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
|
